Viridian Therapeutics, Inc. Common Stock (VRDN)

Viridian Therapeutics (VRDN) stock hits 52-week high amid positive analyst sentiment and successful public offering, though social media engagement shows a recent dip.

About Viridian Therapeutics, Inc. Common Stock

Viridian Therapeutics, Inc. is a biotechnology company focused on therapies for thyroid eye disease.
Viridian Therapeutics, Inc. Common Stock uses the ticker $VRDN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Viridian Therapeutics, Inc. Common Stock (VRDN) social dominance is up 250% from the previous week.
Viridian Therapeutics, Inc. Common Stock (VRDN) engagements is up 121.82% from the previous [--] months.

Price: $27.90

Price 24-Hour Time-Series Raw Data
The stock price has reached a 52-week high, supported by positive analyst sentiment and a successful public offering, despite a recent 24-hour dip and declining social media engagement.

24-Hour: -3.02% 7-Day: -5.17% 30-Day: -16.12%

1-Year High: $33.80 on 2026-01-14
1-Year Low: $11 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Viridian Therapeutics, Inc. Common Stock (VRDN) is currently AltRank #1,109 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +145
[--] Month: [-----] +286
[--] Months: [-----] +613
[--] Year: [-----] +798
1-Year High: [-----] on 2026-01-26
1-Year Low: [--] on 2025-11-23

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +4
1-Year High: [--] on 2025-12-22
1-Year Low: [--] on 2025-12-02

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +94%
[--] Month: [-------] +39%
[--] Months: [-------] +57%
[--] Year: [---------] -48%
1-Year High: [------] on 2025-12-14
1-Year Low: [--] on 2025-04-21

Engagements by network (24h): News: [--] X: [-----] YouTube: [--] Reddit: [--] TikTok: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +4.90%
[--] Month: [---] +82%
[--] Months: [-----] -16%
[--] Year: [-----] +70%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-11

Mentions by network (24h): News: [--] X: [--] YouTube: [--] Reddit: [--] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Viridian Therapeutics, Inc. Common Stock (VRDN) in the last [--] hours which is down 24% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -4.70%
[--] Month: [---] +76%
[--] Months: [---] -51%
[--] Year: [-----] +161%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-11

The most influential creators that mention Viridian Therapeutics, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@Andre_AGTC	[--]	[-----]	[--]	[-----]
@stockmktgenius	[--]	[------]	[--]	[--]
@SteveDJacobs	[--]	[------]	[--]	[--]
@StockConsultant	[--]	[-----]	[--]	[--]

Sentiment: 88%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 88%
Daily Average: 87%
[--] Week: 100% no change
[--] Month: 90% +20%
[--] Months: 90% -10%
[--] Year: 90% -10%
1-Year High: 100% on 2025-02-17
1-Year Low: 14% on 2025-09-22

Most Supportive Themes:

Analyst Upgrades and Price Targets: (40%) Financial analysts have increased their price targets for Viridian Therapeutics, indicating positive sentiment from the financial community.
Public Offering and Financial Health: (30%) The company's recent public offering has strengthened its financial position, providing resources for future development.
Regulatory Milestones: (20%) The submission of a Biologics License Application (BLA) to the FDA for veligrotug is a significant step towards potential market approval.

Most Critical Themes:

Declining Social Media Engagement: (15%) Despite positive company news, social media interest is decreasing, with notable drops in engagement and mentions.

Social Dominance: 0.0032%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0032%
Daily Average: 0.00511%
[--] Week: 0.011% +0.0075%
[--] Month: 0.0049% +0.0007999999999999995%
[--] Months: 0.0049% -0.0012%
[--] Year: 0.0049% -0.0033%
1-Year High: 0.033% on 2025-06-29
1-Year Low: 0.0005% on 2025-10-11

Market Dominance: 0.00302%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00302%
Daily Average: 0%
1-Year High: 0.129% on 2026-02-06
1-Year Low: 0.00302% on 2026-02-16

Market Cap: $2,662,832,023

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,662,832,023
Daily Average: $2,996,580,131
[--] Week: $2,643,743,622 -6.40%
[--] Month: $2,662,832,023 -16%
1-Year High: $3,224,031,030 on 2026-01-14
1-Year Low: $2,662,832,023 on 2026-02-13

Top Viridian Therapeutics, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$LRHC La Rosa Holdings Corp. Signs Contract to Acquire Development Site for Up to [-----] Sq. Ft. Tier III AI Data Center in Central Floridas Fastest-Growing Region $ILLR $TSLA $SPY $TNXP $LEAS $LRMR $ASPI $SMCI $VRDN $MSTR $RCAT $WKEY $IOVA https://www.stocktitan.net/news/LRHC/la-rosa-holdings-corp-signs-contract-to-acquire-development-site-for-rpfxspg61695.html https://www.stocktitan.net/news/LRHC/la-rosa-holdings-corp-signs-contract-to-acquire-development-site-for-rpfxspg61695.html"
X Link @TradesProfits 2026-02-15T18:02Z [---] followers, [---] engagements

"#Deeptrack Feb 13'26 Massive $XBI put 22% of portfolio Vary bearish move👀 Changed position of interest $XBI put New #1 $IMVT +19% #2 $AXSM +28% #7 $CYTK -22% #6 $VRDN -53% #19"
X Link @Andre_AGTC 2026-02-14T18:26Z [----] followers, [----] engagements

"Each quarter we identify major catalyst events 🚨 Likely to move the stock +/- by 20% $NKTR Rezpegaldesleukin (NKTR-358) Ph2b $RGNX RGX-202 Ph2/3 $VRDN Veligrotug (formerly VRDN-001) PDUFA Access our FREE Big Mover Report below 👇 https://www.offers.bpiq.com/big-mover-lpmo=jun https://www.offers.bpiq.com/big-mover-lpmo=jun"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, [----] engagements

"My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3"
X Link @Andre_AGTC 2026-02-12T14:13Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing